Selected Abstract Presentations: Safety and immunogenicity of a Klebsiella pneumoniae tetravalent bioconjugate vaccine (Kleb4V) administered to healthy adults: A FTIH phase I/II randomized and controlled study

Cristina Alaimo, Clinical Director, LimmaTech Biologics, Switzerland

14:10 - 14:23 Monday 27 February Afternoon

+ Add to Calendar

More sessions on Registration